Mi-Ok Kim, PhD, MS, MA
Professor
Epidemiology & Biostatistics
School of Medicine

I am Professor of Biostatistics in the Department of Epidemiology and Biostatistics and Director of the Helen Diller Family Comprehensive Cancer Center Biostatistics and Population Research Shared Resource at UCSF. My method research interests include the theory and application of adaptive clinical trial designs, semi- and non-parametric analysis of longitudinal and survival data, and causal inference. I have collaborated in cancer and inflammatory bowel disease research.

Awards

Show all (1) Hide

• Crohn’s and Colitis Foundation Uniting to Care and Cure Award, Crohn’s and Colitis Foundation of America, 2017

Education & Training

Show all (2) Hide

• MS Statistics University of Illinois at Urbana-Champaign 2003
• PhD Statistics University of Illinois at Urbana-Champaign 2003

Interests

Show all (5) Hide

• Inflammatory bowel disease
• Clinical trials
• Causal inference
• Cancer
• Biostatistics

Grants and Projects

Show all (8) Hide

• Mixed Data Meta-analysis: Integration of Individual Participant and Aggregate Data, PCORI, 2021-2024
• Cancer Center Support Grant, NIH, 1999-2023
• Risk Stratification & Identification of immunogenic and microbial markers of rapid disease progression in children with Crohn’s disease, CCFA, 2008-2018
• Propensity Score-based Methods for CER Using Multilevel Data: What Works Best When, PCORI, 2015-2018
• Rigor of Multi-Registry CER Studies: Towards Patient-Centered Treatment Planning, NIH, 2014-2016
• Collaborative Research: Extension of Quantile Regression and Empirical Likelihood Analysis for Censored Data, National Science Foundation (NSF), 2010-2013
• Empirical Likelihood Bayes Analysis of Quantile Regression Model, NIH, 2009-2011
• Empirical Likelihood Inference of Censored Quantile Regression, National Science Foundation (NSF), 2006-2009

Publications (110)

Top publication keywords:
Research DesignHospitals, Low-VolumeBayes TheoremSEER ProgramHospitals, High-VolumeModels, StatisticalIntestinal NeoplasmsCrohn DiseasePropensity ScoreNeurofibromatosis 1Neurofibroma, PlexiformObservational Studies as TopicNeurofibromaNeurofibromin 1Likelihood Functions

• Synthesizing external aggregated information in the presence of population heterogeneity: A penalized empirical likelihood approach.
  Biometrics 2021 Sheng Y, Sun Y, Huang CY, Kim MO
• Genome-Informed Targeted Therapy for Osteosarcoma.
  Cancer discovery 2018 Sayles LC, Breese MR, Koehne AL, Leung SG, Lee AG, Liu HY, Spillinger A, Shah AT, Tanasa B, Straessler K, Hazard FK, Spunt SL, Marina N, Kim GE, Cho SJ, Avedian RS, Mohler DG, Kim MO, DuBois SG, …
• Bayesian selective response-adaptive design using the historical control.
  Statistics in medicine 2018 Kim MO, Harun N, Liu C, Khoury JC, Broderick JP
• Semiparametric Approach to a Random Effects Quantile Regression Model.
  Journal of the American Statistical Association 2011 Kim MO, Yang Y
• Quantile regression decomposition analysis of disparity research using complex survey data: Application to disparities in BMI and telomere length between U.S. minority and white population groups
  Annals of Applied Statistics 2024 Hyokyoung G. Hong. Barry I. Graubard. Joseph L. Gastwirth. Mi-Ok Kim

Show all (105 more) Hide

• Designing monitoring strategies for deployed machine learning algorithms: navigating performativity through a causal lens
  Proceedings of Machine Learning Research 2024 Jean Feng, Adarsh Subbaswamy, Alexej Gossmann, Harvineet Singh, Berkman Sahiner, Mi-Ok Kim, Gene Anthony Pennello, Nicholas Petrick, Romain Pirracchio, Fan Xia
• Differences in Acute Postoperative Opioid Use by English Proficiency, Race, and Ethnicity After Total Knee and Hip Arthroplasty.
  Anesthesia and analgesia 2024 Joo H, Nguyen K, Kolodzie K, Chen LL, Kim MO, Manuel S
• C5aR plus MEK inhibition durably targets the tumor milieu and reveals tumor cell phagocytosis.
  Life science alliance 2024 Perrino MR, Ahmari N, Hall A, Jackson M, Na Y, Pundavela J, Szabo S, Woodruff TM, Dombi E, Kim MO, Köhl J, Wu J, Ratner N
• Characterizing attitudes related to future child-bearing in young women diagnosed with early-stage breast cancer.
  Breast cancer research and treatment 2024 Umashankar S, Li M, Blevins K, Kim MO, Majure M, Park J, Huppert LA, Melisko M, Rugo HS, Esserman L, Chien AJ
• Breastfeeding and Once-Daily Small-Volume Formula Supplementation to Prevent Infant Growth Impairment.
  Pediatrics 2024 Flaherman VJ, Murungi J, Bale C, Dickinson S, Chen X, Namiiro F, Nankunda J, Pollack LM, Laleau V, Kim MO, Allison DB, Ginsburg AS, Braima de Sa A, Nankabirwa V
• Simultaneous selection and incorporation of consistent external aggregate information.
  Statistics in medicine 2023 Huang Y, Huang CY, Kim MO
• Bayesian adaptive design for covariate-adaptive historical control information borrowing.
  Statistics in medicine 2023 Jin H, Kim MO, Scheffler A, Jiang F
• Opposing effects of KDM6A and JDP2 on glucocorticoid sensitivity in T-ALL.
  Blood advances 2023 Levinson AL, Tjoa K, Huang B, Meyer LK, Kim MO, Brady SW, Zhang J, Shannon K, Wandler AM
• Broad- Versus Narrow-Spectrum Perioperative Antibiotics and Outcomes in Pediatric Congenital Heart Disease Surgery: Analysis of the Vizient Clinical Data Base.
  Journal of the Pediatric Infectious Diseases Society 2023 Cooch PB, Kim MO, Swami N, Tamma PD, Tabbutt S, Steurer MA, Wattier RL
• Neighborhood attributes and cardiovascular disease risk in breast cancer survivors: The Pathways Study.
  Cancer 2023 Conroy SM, Von Behren J, Kwan ML, Kushi LH, Kim MO, Iribarren C, Roh JM, Laurent CA, Thomsen C, Chu JN, Greenlee H, Gomez SL, Shariff-Marco S
• Combining SOS1 and MEK Inhibitors in a Murine Model of Plexiform Neurofibroma Results in Tumor Shrinkage.
  The Journal of pharmacology and experimental therapeutics 2023 Jackson M, Ahmari N, Wu J, Rizvi TA, Fugate E, Kim MO, Dombi E, Arnhof H, Boehmelt G, Düchs MJ, Long CJ, Maier U, Trapani F, Hofmann MH, Ratner N
• Towards a Post-Market Monitoring Framework for Machine Learning-based Medical Devices: A case study
  Workshop on Regulatable Machine Learning at the 37th Conference on Neural Information Processing Systems 2023 Jean Feng, Adarsh Subbaswamy, Alexej Gossmann, Harvineet Singh, Berkman Sahiner, Mi-Ok Kim, Gene Pennello, Nicholas Petrick, Romain Pirracchio, and Fan Xia
• Optimizing intervention tools to improve nutrition and physical activity for colorectal cancer survivors (Tools To Be Fit): Study protocol of a randomized factorial experiment.
  Contemporary clinical trials 2022 Kenfield SA, Philip EJ, Phillips SM, Meyerhardt JA, Chan JM, Atreya CE, Kim MO, Harris Q, Steiding P, Macaire G, McCullough ML, Piawah S, Johnson WY, Kurttila FA, Lewis WL, Pesmen C, Watson Y, Van …
• Assessing Unique Risk Factors for COVID-19 Complications Among Cancer Patients: A Multi-ethnic Cohort Study.
  Journal of immigrant and minority health 2022 Borno HT, Kim MO, Tolstykh I, Lin A, Hong JC, Yousefi S, Zhang S, McKay RR, Harismendy O, Razavi P, Cinar P, Rugo H, Koshkin VS, Rabow M, Wang C, Bailey A, Small EJ
• Clinical characteristics and outcomes in patients with metastatic breast cancer and pseudocirrhosis: a single center retrospective cohort study.
  Breast cancer research and treatment 2022 Huppert LA, Walker Z, Li M, Kim MO, Callan J, Brandman D, Majure M, Melisko ME, Rugo HS, Behr S, Chien AJ
• STAT3 Activation as a Predictive Biomarker for Ruxolitinib Response in Head and Neck Cancer.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2022 Qureshy Z, Li H, Zeng Y, Rivera J, Cheng N, Peterson CN, Kim MO, Ryan WR, Ha PK, Bauman JE, Wang SJ, Long SR, Johnson DE, Grandis JR
• Effect of Social Needs Case Management on Hospital Use Among Adult Medicaid Beneficiaries : A Randomized Study.
  Annals of internal medicine 2022 Brown DM, Hernandez EA, Levin S, De Vaan M, Kim MO, Lynch C, Roth A, Brewster AL
• COVID-19 Outcomes Among Patients With Cancer: Observations From the University of California Cancer Consortium COVID-19 Project Outcomes Registry.
  The oncologist 2022 Borno HT, Kim MO, Hong JC, Yousefi S, Lin A, Tolstykh I, Zhang S, McKay RR, Harismendy O, Cinar P, Rugo H, Koshkin VS, Rabow M, Wang C, Bailey A, Small EJ
• Randomized controlled trial of early, small-volume formula supplementation among newborns: A study protocol.
  PloS one 2022 Ginsburg AS, Braima de Sa A, Nankabirwa V, Co R, Murungi J, Kim MO, Brim R, Namiiro F, Namugga O, Hartigan-O'Connor DJ, Roberts SB, Flaherman V
• Feasibility and Acceptability of a Physical Activity Tracker and Text Messages to Promote Physical Activity During Chemotherapy for Colorectal Cancer: Pilot Randomized Controlled Trial (Smart Pace II).
  JMIR cancer 2022 Van Blarigan EL, Dhruva A, Atreya CE, Kenfield SA, Chan JM, Milloy A, Kim I, Steiding P, Laffan A, Zhang L, Piawah S, Fukuoka Y, Miaskowski C, Hecht FM, Kim MO, Venook AP, Van Loon K
• Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients.
  The Lancet. Oncology 2021 Yau C, Osdoit M, van der Noordaa M, Shad S, Wei J, de Croze D, Hamy AS, Laé M, Reyal F, Sonke GS, Steenbruggen TG, van Seijen M, Wesseling J, Martín M, Del Monte-Millán M, López-Tarruella S, I-SPY 2 …
• Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma.
  The Journal of clinical investigation 2021 Jin N, Keam B, Cho J, Lee MJ, Kim HR, Torosyan H, Jura N, Ng PK, Mills GB, Li H, Zeng Y, Barbash Z, Tarcic G, Kang H, Bauman JE, Kim MO, VanLandingham NK, Swaney DL, Krogan NJ, Johnson DE, Grandis JR
• Dynamic Risk Prediction for Hospital-Acquired Pressure Injury in Adult Critical Care Patients.
  Critical care explorations 2021 Shui AM, Kim P, Aribindi V, Huang CY, Kim MO, Rangarajan S, Schorger K, Aldrich JM, Lee H
• Update on Phototherapy and Childhood Cancer in a Northern California Cohort.
  Pediatrics 2021 Digitale JC, Kim MO, Kuzniewicz MW, Newman TB
• Perioperative Normal Saline Administration and Delayed Graft Function in Patients Undergoing Kidney Transplantation: A Retrospective Cohort Study.
  Anesthesiology 2021 Kolodzie K, Cakmakkaya OS, Boparai ES, Tavakol M, Feiner JR, Kim MO, Newman TB, Niemann CU
• Predictive generalized varying-coefficient longitudinal model.
  Statistics in medicine 2021 Kim S, Ryan Cho H, Kim MO
• PD-L1 is upregulated via BRD2 in head and neck squamous cell carcinoma models of acquired cetuximab resistance.
  Head & neck 2021 Bhola NE, Njatcha C, Hu L, Lee ED, Shiah JV, Kim MO, Johnson DE, Grandis JR
• Synthesizing external aggregated information in the penalized Cox regression under population heterogeneity.
  Statistics in medicine 2021 Sheng Y, Sun Y, Huang CY, Kim MO
• Effect of treatment center volume on outcomes in gastroenteropancreatic neuroendocrine tumor patients.
  BMC cancer 2021 Baeg K, Harris C, Naparst MS, Ahn E, Thapi S, Martin J, Rustgi S, Mhango G, Wisnivesky J, Kim MK
• Optimal treatment regimes for competing risk data using doubly robust outcome weighted learning with bi-level variable selection.
  Computational statistics & data analysis 2021 He Y, Kim S, Kim MO, Saber W, Ahn KW
• MicroRNA-155 contributes to plexiform neurofibroma growth downstream of MEK.
  Oncogene 2020 Na Y, Hall A, Choi K, Hu L, Rose J, Coover RA, Miller A, Hennigan RF, Dombi E, Kim MO, Subramanian S, Ratner N, Wu J
• Critical appraisal of Bayesian dynamic borrowing from an imperfectly commensurate historical control.
  Pharmaceutical statistics 2020 Harun N, Liu C, Kim MO
• Residual tumor volume discriminates prognosis after surgery for neuroendocrine liver metastasis.
  Journal of surgical oncology 2019 Kasai Y, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Harun N, Kim MO, Warren RS, Bergsland EK, Nakakura EK
• Variation in Care in the Management of Children With Crohn's Disease: Data From a Multicenter Inception Cohort Study.
  Inflammatory bowel diseases 2019 Krishnakumar C, Ballengee CR, Liu C, Kim MO, Baker SS, Baldassano RN, Cohen SA, Crandall WV, Denson LA, Dubinsky MC, Evans J, Gokhale R, Griffiths A, Guthery SL, Oliva-Hemker M, Heyman MB, Keljo D, …
• Propensity score analysis for correlated subgroup effects.
  Statistical methods in medical research 2019 Liu SY, Liu C, Nehus E, Macaluso M, Lu B, Kim MO
• RUNX represses Pmp22 to drive neurofibromagenesis.
  Science advances 2019 Hall A, Choi K, Liu W, Rose J, Zhao C, Yu Y, Na Y, Cai Y, Coover RA, Lin Y, Dombi E, Kim M, Levanon D, Groner Y, Boscolo E, Pan D, Liu PP, Lu QR, Ratner N, Huang G, Wu J
• Cxcr3-expressing leukocytes are necessary for neurofibroma formation in mice.
  JCI insight 2019 Fletcher JS, Wu J, Jessen WJ, Pundavela J, Miller JA, Dombi E, Kim MO, Rizvi TA, Chetal K, Salomonis N, Ratner N
• Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for PIK3CA-altered head and neck cancer.
  The Journal of experimental medicine 2019 Hedberg ML, Peyser ND, Bauman JE, Gooding WE, Li H, Bhola NE, Zhu TR, Zeng Y, Brand TM, Kim MO, Jordan RCK, VandenBerg S, Olivas V, Bivona TG, Chiosea SI, Wang L, Mills GB, Johnson JT, Duvvuri U, …
• Age-of-diagnosis dependent ileal immune intensification and reduced alpha-defensin in older versus younger pediatric Crohn Disease patients despite already established dysbiosis.
  Mucosal immunology 2018 Haberman Y, Schirmer M, Dexheimer PJ, Karns R, Braun T, Kim MO, Walters TD, Baldassano RN, Noe JD, Rosh J, Markowitz J, Crandall WV, Mack DR, Griffiths AM, Heyman MB, Baker SS, Kellermayer R, Moulton …
• STAT3 inhibition reduces macrophage number and tumor growth in neurofibroma.
  Oncogene 2018 Fletcher JS, Springer MG, Choi K, Jousma E, Rizvi TA, Dombi E, Kim MO, Wu J, Ratner N
• COMPARISON OF EXTENDED EMPIRICAL LIKELIHOOD METHODS: SIZE AND SHAPE OF TEST BASED CONFIDENCE REGIONS
  Statistica Sinica 2018 Kim MO, Zhou M
• Estimating heterogeneous treatment effects for latent subgroups in observational studies.
  Statistics in medicine 2018 Kim HJ, Lu B, Nehus EJ, Kim MO
• Evolution of Pediatric Inflammatory Bowel Disease Unclassified (IBD-U): Incorporated With Serological and Gene Expression Profiles.
  Inflammatory bowel diseases 2018 Chandradevan R, Hofmekler T, Mondal K, Harun N, Venkateswaran S, Somineni HK, Ballengee CR, Kim MO, Griffiths A, Noe JD, Crandall WV, Snapper S, Rabizadeh S, Rosh JR, Walters TD, Bertha M, Dubinsky MC…
• Association Between Plasma Level of Collagen Type III Alpha 1 Chain and Development of Strictures in Pediatric Patients With Crohn's Disease.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2018 Ballengee CR, Stidham RW, Liu C, Kim MO, Prince J, Mondal K, Baldassano R, Dubinsky M, Markowitz J, Leleiko N, Hyams J, Denson L, Kugathasan S
• Familial Association of Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in Inflammatory Bowel Disease.
  Journal of pediatric gastroenterology and nutrition 2018 Wright SS, Trauernicht A, Bonkowski E, McCall CA, Maier EA, Bezold R, Lake K, Chalk C, Trapnell BC, Kim MO, Kugathasan S, Denson LA
• Transcriptional risk scores link GWAS to eQTLs and predict complications in Crohn's disease.
  Nature genetics 2017 Marigorta UM, Denson LA, Hyams JS, Mondal K, Prince J, Walters TD, Griffiths A, Noe JD, Crandall WV, Rosh JR, Mack DR, Kellermayer R, Heyman MB, Baker SS, Stephens MC, Baldassano RN, Markowitz JF, Kim…
• Erratum to: Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy.
  Breast cancer research and treatment 2017 Chien AJ, Chambers J, Mcauley F, Kaplan T, Letourneau J, Hwang J, Kim MO, Melisko ME, Rugo HS, Esserman LJ, Rosen MP
• Graft survival of pediatric kidney transplant recipients selected for de novo steroid avoidance-a propensity score-matched study.
  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2017 Nehus EJ, Liu C, Lu B, Macaluso M, Kim MO
• Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy.
  Breast cancer research and treatment 2017 Chien AJ, Chambers J, Mcauley F, Kaplan T, Letourneau J, Hwang J, Kim MO, Melisko ME, Rugo HS, Esserman LJ, Rosen MP
• Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study.
  Lancet (London, England) 2017 Kugathasan S, Denson LA, Walters TD, Kim MO, Marigorta UM, Schirmer M, Mondal K, Liu C, Griffiths A, Noe JD, Crandall WV, Snapper S, Rabizadeh S, Rosh JR, Shapiro JM, Guthery S, Mack DR, Kellermayer R…
• Multiple quantile regression analysis of longitudinal data: Heteroscedasticity and efficient estimation
  Journal of Multivariate Analysis 2017 Cho H, Kim S, Kim MO
• Rapid Lentiviral Transduction Preserves the Engraftment Potential of Fanca-/- Hematopoietic Stem Cells.
  Molecular therapy : the journal of the American Society of Gene Therapy 2016 Müller LU, Milsom MD, Kim MO, Schambach A, Schuesler T, Williams DA
• A comparison of safety and efficacy of cytotoxic versus molecularly targeted drugs in pediatric phase I solid tumor oncology trials.
  Pediatric blood & cancer 2016 Dorris K, Liu C, Li D, Hummel TR, Wang X, Perentesis J, Kim MO, Fouladi M
• Frequency and risks associated with Clostridium difficile-associated diarrhea after pediatric solid organ transplantation: a single-center retrospective review.
  Transplant infectious disease : an official journal of the Transplantation Society 2016 Ciricillo J, Haslam D, Blum S, Kim MO, Liu C, Paulsen G, Courter J, Danziger-Isakov L
• Random-effects meta-analysis for systematic reviews of phase I clinical trials: Rare events and missing data.
  Research synthesis methods 2016 Kim MO, Wang X, Liu C, Dorris K, Fouladi M, Song S
• Practical Use of Infliximab Concentration Monitoring in Pediatric Crohn Disease.
  Journal of pediatric gastroenterology and nutrition 2016 Minar P, Saeed SA, Afreen M, Kim MO, Denson LA
• Efficient quantile marginal regression for longitudinal data with dropouts.
  Biostatistics (Oxford, England) 2016 Cho H, Hong HG, Kim MO
• Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.
  Cell reports 2016 Wu J, Keng VW, Patmore DM, Kendall JJ, Patel AV, Jousma E, Jessen WJ, Choi K, Tschida BR, Silverstein KA, Fan D, Schwartz EB, Fuchs JR, Zou Y, Kim MO, Dombi E, Levy DE, Huang G, Cancelas JA, Stemmer-…
• Practice of Causal Inference with the Propensity of Being Zero or One: Assessing the Effect of Arbitrary Cutoffs of Propensity Scores
  Communications for Statistical Applications and Methods 2016 Kang J, Chan W, Kim MO, Steiner PM
• Runx1 contributes to neurofibromatosis type 1 neurofibroma formation.
  Oncogene 2015 Li H, Zhao X, Yan X, Jessen WJ, Kim MO, Dombi E, Liu PP, Huang G, Wu J
• Preclinical assessments of the MEK inhibitor PD-0325901 in a mouse model of Neurofibromatosis type 1.
  Pediatric blood & cancer 2015 Jousma E, Rizvi TA, Wu J, Janhofer D, Dombi E, Dunn RS, Kim MO, Masters AR, Jones DR, Cripe TP, Ratner N
• Corrigendum. Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature.
  The Journal of clinical investigation 2015 Haberman Y, Tickle TL, Dexheimer PJ, Kim MO, Tang D, Karns R, Baldassano RN, Noe JD, Rosh J, Markowitz J, Heyman MB, Griffiths AM, Crandall WV, Mack DR, Baker SS, Huttenhower C, Keljo DJ, Hyams JS, …
• Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature.
  The Journal of clinical investigation 2014 Haberman Y, Tickle TL, Dexheimer PJ, Kim MO, Tang D, Karns R, Baldassano RN, Noe JD, Rosh J, Markowitz J, Heyman MB, Griffiths AM, Crandall WV, Mack DR, Baker SS, Huttenhower C, Keljo DJ, Hyams JS, …
• Utility of neutrophil Fcγ receptor I (CD64) index as a biomarker for mucosal inflammation in pediatric Crohn's disease.
  Inflammatory bowel diseases 2014 Minar P, Haberman Y, Jurickova I, Wen T, Rothenberg ME, Kim MO, Saeed SA, Baldassano RN, Stephens M, Markowitz J, Rosh J, Crandall WV, Heyman MB, Mack DR, Griffiths AM, Baker SS, Hyams JS, Kugathasan …
• Outcome-adaptive randomization for a delayed outcome with a short-term predictor: imputation-based designs.
  Statistics in medicine 2014 Kim MO, Liu C, Hu F, Lee JJ
• Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's disease.
  Gastroenterology 2013 Walters TD, Kim MO, Denson LA, Griffiths AM, Dubinsky M, Markowitz J, Baldassano R, Crandall W, Rosh J, Pfefferkorn M, Otley A, Heyman MB, LeLeiko N, Baker S, Guthery SL, Evans J, Ziring D, …
• An intermediate alemtuzumab schedule reduces the incidence of mixed chimerism following reduced-intensity conditioning hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis.
  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013 Marsh RA, Kim MO, Liu C, Bellman D, Hart L, Grimley M, Kumar A, Jodele S, Myers KC, Chandra S, Leemhuis T, Mehta PA, Bleesing JJ, Davies SM, Jordan MB, Filipovich AH
• Everolimus treatment of refractory epilepsy in tuberous sclerosis complex.
  Annals of neurology 2013 Krueger DA, Wilfong AA, Holland-Bouley K, Anderson AE, Agricola K, Tudor C, Mays M, Lopez CM, Kim MO, Franz DN
• Oxandrolone for the treatment of bone marrow failure in Fanconi anemia.
  Pediatric blood & cancer 2013 Rose SR, Kim MO, Korbee L, Wilson KA, Ris MD, Eyal O, Sherafat-Kazemzadeh R, Bollepalli S, Harris R, Jeng MR, Williams DA, Smith FO
• Increased prevalence of luminal narrowing and stricturing identified by enterography in pediatric Crohn's disease patients with elevated granulocyte-macrophage colony stimulating factor autoantibodies.
  Inflammatory bowel diseases 2013 Dykes DM, Towbin AJ, Bonkowski E, Chalk C, Bezold R, Lake K, Kim MO, Heubi JE, Trapnell BC, Podberesky DJ, Denson LA
• Granulocyte-macrophage colony-stimulating factor autoantibodies: a marker of aggressive Crohn's disease.
  Inflammatory bowel diseases 2013 Gathungu G, Kim MO, Ferguson JP, Sharma Y, Zhang W, Ng SM, Bonkowski E, Ning K, Simms LA, Croft AR, Stempak JM, Walker N, Huang N, Xiao Y, Silverberg MS, Trapnell B, Cho JH, Radford-Smith GL, Denson …
• MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors.
  The Journal of clinical investigation 2012 Jessen WJ, Miller SJ, Jousma E, Wu J, Rizvi TA, Brundage ME, Eaves D, Widemann B, Kim MO, Dombi E, Sabo J, Hardiman Dudley A, Niwa-Kawakita M, Page GP, Giovannini M, Aronow BJ, Cripe TP, Ratner N
• Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes.
  Blood 2012 Marsh RA, Rao K, Satwani P, Lehmberg K, Müller I, Li D, Kim MO, Fischer A, Latour S, Sedlacek P, Barlogis V, Hamamoto K, Kanegane H, Milanovich S, Margolis DA, Dimmock D, Casper J, Douglas DN, Amrolia…
• Improved outcomes for stem cell transplant recipients requiring pediatric intensive care.
  Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 2012 Chima RS, Daniels RC, Kim MO, Li D, Wheeler DS, Davies SM, Jodele S
• Neurofibroma-associated macrophages play roles in tumor growth and response to pharmacological inhibition.
  Acta neuropathologica 2012 Prada CE, Jousma E, Rizvi TA, Wu J, Dunn RS, Mayes DA, Cancelas JA, Dombi E, Kim MO, West BL, Bollag G, Ratner N
• A high-resolution analysis of process improvement: use of quantile regression for wait time.
  Health services research 2012 Choi D, Hoffman KA, Kim MO, McCarty D
• The fanconi anemia pathway limits human papillomavirus replication.
  Journal of virology 2012 Hoskins EE, Morreale RJ, Werner SP, Higginbotham JM, Laimins LA, Lambert PF, Brown DR, Gillison ML, Nuovo GJ, Witte DP, Kim MO, Davies SM, Mehta PA, Butsch Kovacic M, Wikenheiser-Brokamp KA, Wells SI
• Empirical Likelihood Analysis for the Heteroscedastic Accelerated Failure Time Model
  Statistica Sinica 2012 Zhou M, Kim MO and Bathke A
• Journal of Agricultural, Biological, and Environmental Statistics
  Claus Thorn Ekstrom and Helle Sorensen: Statistical Data Analysis for the Life Sciences 2012 Kim MO
• Censored quantile regression for residual lifetimes.
  Lifetime data analysis 2011 Kim MO, Zhou M, Jeong JH
• Biomarkers for early detection of sickle nephropathy.
  American journal of hematology 2011 Sundaram N, Bennett M, Wilhelm J, Kim MO, Atweh G, Devarajan P, Malik P
• Granulocyte macrophage-colony-stimulating factor autoantibodies and increased intestinal permeability in Crohn disease.
  Journal of pediatric gastroenterology and nutrition 2011 Nylund CM, D'Mello S, Kim MO, Bonkowski E, Däbritz J, Foell D, Meddings J, Trapnell BC, Denson LA
• The impact of the 2009 H1N1 influenza pandemic on pediatric patients with sickle cell disease.
  Pediatric blood & cancer 2011 George A, Benton J, Pratt J, Kim MO, Kalinyak KA, Kalfa TA, Joiner CH
• Preclincial testing of sorafenib and RAD001 in the Nf(flox/flox) ;DhhCre mouse model of plexiform neurofibroma using magnetic resonance imaging.
  Pediatric blood & cancer 2011 Wu J, Dombi E, Jousma E, Scott Dunn R, Lindquist D, Schnell BM, Kim MO, Kim A, Widemann BC, Cripe TP, Ratner N
• The Timing of Alemtuzumab Significantly Impacts Mixed Chimerism and Acute Graft Versus Host Disease
  Biology of Blood and Marrow Transplantation 2011 Marsh RA, Li D, Kim MO, Hart L, Joshi S, Jodele S, Mehta P, Jordan MB, Bleesing JJ, Davies SM, Filipovich AH
• Numerical chromosomal changes and risk of development of myelodysplastic syndrome--acute myeloid leukemia in patients with Fanconi anemia.
  Cancer genetics and cytogenetics 2010 Mehta PA, Harris RE, Davies SM, Kim MO, Mueller R, Lampkin B, Mo J, Myers K, Smolarek TA
• Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation.
  Blood 2010 Marsh RA, Vaughn G, Kim MO, Li D, Jodele S, Joshi S, Mehta PA, Davies SM, Jordan MB, Bleesing JJ, Filipovich AH
• Improved recipient survival with maternal nifedipine in twin-twin transfusion syndrome complicated by TTTS cardiomyopathy undergoing selective fetoscopic laser photocoagulation.
  American journal of obstetrics and gynecology 2010 Crombleholme TM, Lim FY, Habli M, Polzin W, Jaekle R, Michelfelder E, Cnota J, Liu C, Kim MO
• Mammary gland differentiation by early life exposure to enantiomers of the soy isoflavone metabolite equol.
  Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 2010 Brown NM, Belles CA, Lindley SL, Zimmer-Nechemias L, Witte DP, Kim MO, Setchell KD
• A randomized controlled trial of growth hormone in active pediatric Crohn disease.
  Journal of pediatric gastroenterology and nutrition 2010 Denson LA, Kim MO, Bezold R, Carey R, Osuntokun B, Nylund C, Willson T, Bonkowski E, Li D, Ballard E, Collins M, Moyer MS, Klein DJ
• Statistical issues in longitudinal data analysis for treatment efficacy studies in the biomedical sciences.
  Molecular therapy : the journal of the American Society of Gene Therapy 2010 Liu C, Cripe TP, Kim MO
• The chemopreventive action of equol enantiomers in a chemically induced animal model of breast cancer.
  Carcinogenesis 2010 Brown NM, Belles CA, Lindley SL, Zimmer-Nechemias LD, Zhao X, Witte DP, Kim MO, Setchell KD
• Patients with X-linked lymphoproliferative disease due to BIRC4 mutation have normal invariant natural killer T-cell populations.
  Clinical immunology (Orlando, Fla.) 2009 Marsh RA, Villanueva J, Kim MO, Zhang K, Marmer D, Risma KA, Jordan MB, Bleesing JJ, Filipovich AH
• Ectopic HOXB4 overcomes the inhibitory effect of tumor necrosis factor-{alpha} on Fanconi anemia hematopoietic stem and progenitor cells.
  Blood 2009 Milsom MD, Schiedlmeier B, Bailey J, Kim MO, Li D, Jansen M, Ali AM, Kirby M, Baum C, Fairbairn LJ, Williams DA
• Combined multiple testing by censored empirical likelihood
  Journal of Statistical Planning and Inference 2009 Bathke A, Kim, MO, Zhou M
• Granulocyte-macrophage colony-stimulating factor autoantibodies in murine ileitis and progressive ileal Crohn's disease.
  Gastroenterology 2008 Han X, Uchida K, Jurickova I, Koch D, Willson T, Samson C, Bonkowski E, Trauernicht A, Kim MO, Tomer G, Dubinsky M, Plevy S, Kugathsan S, Trapnell BC, Denson LA
• Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.
  Molecular cancer therapeutics 2008 Johansson G, Mahller YY, Collins MH, Kim MO, Nobukuni T, Perentesis J, Cripe TP, Lane HA, Kozma SC, Thomas G, Ratner N
• Evaluation of orthodontic mini-implant anchorage in premolar extraction therapy in adolescents.
  American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics 2008 Garfinkle JS, Cunningham LL, Beeman CS, Kluemper GT, Hicks EP, Kim MO
• Rapid lentiviral transduction preserves the engraftment potential of Fanca(-/-) hematopoietic stem cells.
  Molecular therapy : the journal of the American Society of Gene Therapy 2008 Müller LU, Milsom MD, Kim MO, Schambach A, Schuesler T, Williams DA
• Empirical Likelihood for Linear Models in the Presence of Nuisance Parameters
  Statistics and Probability Letters 2008 Kim MO, Zhou M
• Small pituitary size in children with Fanconi anemia.
  Pediatric blood & cancer 2007 Sherafat-Kazemzadeh R, Mehta SN, Care MM, Kim MO, Williams DA, Rose SR, Fanconi Anemia Comprehensive Care Center
• Quantile Regression with Varying Coefficients
  Annals of Statistics 2007 Kim MO
• Case report: lymphoma arising in an ileal pouch anal anastomosis after immunomodulatory therapy for inflammatory bowel disease.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2006 Schwartz LK, Kim MK, Coleman M, Lichtiger S, Chadburn A, Scherl E
• Quantile Regression with Shape-Constrained Varying Coefficients
  Sankhyā: The Indian Journal of Statistics 2006 Kim MO
• On Marginal Estimation in a Semiparametric Model for Longitudinal Data with Time-Independent Covariates
  Metrika 2002 He X, Kim MO